Elevated levels of PLA2R1 are associated with pancreatic, gastric, prostate and ovarian carcinomas, while it is downregulated in leukemia, kidney, thyroid and breast carcinomas [3,4,5,6,7,8]. Here, PLA2R1 is linked to breast carcinoma.